Ledger.Open graph →
SEC Form D · filed October 8, 2014

Aclaris Therapeutics, Inc

Offering
$21.3M
Sold
$10.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MALVERN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Kamil D. Ali-Jackson · Malvern, PAExecStephen A. Tullman · Malvern, PADirectorFrank D. Ruffo · Malvern, PAExecStuart D. Shanler · Malvern, PAExecChristopher Powala · Malvern, PAExecNeal Walker · Malvern, PAExec · DirectorAlbert Cha · Palo Alto, CADirectorKetan Patel · Cambridge, MADirectorEden Shochat · San Francisco, CAExecRaymond Martin · Santa Clara, CADirectorStuart Browne · SCOTTSDALE, AZExecAnand Mehra · BRANFORD, CTDirectorItai Danino · San Francisco, CAExec · DirectorBen Rubin · San Francisco, CADirectorDaniel G. Goldberg · New York, NYExec · DirectorJustin G. Gorenkoff · New York, NYExec · DirectorIndia GP LLC · Santa Monica, CAExec · DirectorBill Mccullen · Boston, MADirectorLee Taylor · Boston, MAExecJonathan R. Baldwin · New York, NYExecAnand Mehra · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗